Definium Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
DFTX Nasdaq 2830 definiumtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Definium Therapeutics, Inc.

Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - Aug 6th, 2026 2:01 pm
Definium Therapeutics Announces New Employee Inducement Grants - Aug 3rd, 2026 2:01 pm
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High? - Jul 31st, 2026 7:55 am
Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 30th, 2026 2:01 pm
Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment - Jul 30th, 2026 7:21 am
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners - Jul 27th, 2026 8:38 am
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva - Jul 22nd, 2026 11:25 am
Definium Therapeutics (DFTX) Highlights GAD Care Gaps, Is The Stock Already Overvalued? - Jul 22nd, 2026 8:14 am
How New GAD Treatment Gap Data At Definium Therapeutics (DFTX) Has Changed Its Investment Story - Jul 22nd, 2026 1:10 am
Psychedelic drugs are going mainstream - Jul 20th, 2026 10:00 pm
Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology - Jul 16th, 2026 5:00 am
Is Definium Therapeutics, Inc. (DFTX) Stock a Biotech Opportunity After Positive DT120 Depression Trial Data? - Jul 15th, 2026 3:24 am
The Race to Commercialize the World’s Most Powerful Psychedelic - Jul 14th, 2026 1:00 pm
Wall Street Analysts Think Definium Therapeutics, Inc. (DFTX) Could Surge 32.42%: Read This Before Placing a Bet - Jul 14th, 2026 7:55 am
New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD) - Jul 14th, 2026 5:00 am
Leaderboard Quarterly Scorecard Webinar Q&A Summary For Thursday, July 9, 2026 - Jul 9th, 2026 4:33 pm
Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update? - Jun 30th, 2026 7:21 am
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services - Jun 26th, 2026 5:53 am
To Wall Street, psychedelics biotechs are more teammates than rivals - Jun 24th, 2026 4:56 am
Why Definium Therapeutics (DFTX) Is Up 49.8% After DT120 Phase 3 Win And $700 Million Raise - Jun 23rd, 2026 10:30 pm